journal article·2022-09-21Open access

Curcumin-Encapsulated Nanomicelles Improve Cellular Uptake and Cytotoxicity in Cisplatin-Resistant Human Oral Cancer Cells

Vijay M. Kumbar, Uday Muddapur, Abdullatif Bin Muhsinah, Saad Ali Alshehri, Mohammed Merae Alshahrani, Ibrahim Abdullah Almazni, Manohar S. Kugaji, Kishore Bhat, Malleswara Rao Peram, Mater H. Mahnashi, Sameer J. Nadaf, Sheetalnath B. Rooge, Aejaz Abdullatif Khan, Ibrahim Ahmed Shaikh

Abstract

Oral cancer has a high mortality rate, which is mostly determined by the stage of the disease at the time of admission. Around half of all patients with oral cancer report with advanced illness. Hitherto, chemotherapy is preferred to treat oral cancer, but the emergence of resistance to anti-cancer drugs is likely to occur after a sequence of treatments. Curcumin is renowned for its anticancer potential but its marred water solubility and poor bioavailability limit its use in treating multidrug-resistant cancers. As part of this investigation, we prepared and characterized Curcumin nanomicelles (CUR-NMs) using DSPE-PEG-2000 and evaluated the anticancer properties of cisplatin-resistant cancer cell lines. The prepared CUR-NMs were sphere-shaped and unilamellar in structure, with a size of 32.60 ± 4.2 nm. CUR-NMs exhibited high entrapment efficiency (82.2%), entrapment content (147.96 µg/mL), and a mean zeta potential of −17.5ζ which is considered moderately stable. The cellular uptake and cytotoxicity studies revealed that CUR-NMs had significantly higher cytotoxicity and cellular uptake in cisplatin drug-resistant oral cancer cell lines and parental oral cancer cells compared to plain curcumin (CUR). The DAPI and FACS analysis corroborated a high percentage of apoptotic cells with CUR-NMs (31.14%) compared to neat CUR (19.72%) treatment. Conclusively, CUR-NMs can potentially be used as an alternative carrier system to improve the therapeutic effects of curcumin in the treatment of cisplatin-resistant human oral cancer.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Curcumin's Biomedical Applications · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Central Research Laboratory, Maratha Mandal’s Nathajirao G. Halgekar Institute of Dental Sciences and Research Centre, Belagavi 590010, India

Dr. Prabhakar Kore Basic Science Research Centre, KLE Academy of Higher Education and Research (KLE University), Belagavi 590010, India

Department of Biotechnology, KLE Technological University, Hubballi 580031, India

Department of Pharmacognosy, College of Pharmacy, King Khalid University, Abha 61441, Saudi Arabia

Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran 61441, Saudi Arabia

Chebrolu Hanumaiah Institute of Pharmaceutical Sciences, Guntur 522019, India

Department of Pharmaceutical Chemistry, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia

Sant Gajanan Maharaj College of Pharmacy, Mahagaon 416503, India

Department of Clinical Virology, Institute of Liver and Biliary Sciences, New Delhi 110070, India

Department of General Science, Ibn Sina National College for Medical Studies, Jeddah 21418, Saudi Arabia

Department of Pharmacology, College of Pharmacy, Najran University, Najran 66462, Saudi Arabia

Funding

Deanship of Scientific Research at King Khalid University

References (51)

Show source-provided references
1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries10.3322/caac.21660 ↗
2. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries10.3322/caac.21492 ↗
3. Epidemiologic trends in head and neck cancer and aids in diagnosis10.1016/j.coms.2014.01.001 ↗
4. Tobacco-related carcinogenesis in head and neck cancer10.1007/s10555-017-9689-6 ↗
5. Ketabat, F., Pundir, M., Mohabatpour, F., Lobanova, L., Koutsopoulos, S., Hadjiiski, L., Chen, X., Papagerakis, P., and Papagerakis, S. (2019). Controlled Drug Delivery Systems for Oral Cancer Treatment—Current Status and Future Perspectives. Pharmaceutics, 11.10.3390/pharmaceutics11070302 ↗
6. Herb-anticancer drug interactions in real life based on VigiBase, the WHO global database10.1038/s41598-022-17704-z ↗
7. Medicinal Plants: Their Use in Anticancer Treatment
8. Pandemics and Traditional Plant-Based Remedies. A Historical-Botanical Review in the Era of COVID1910.3389/fpls.2020.571042 ↗
9. Lead Phytochemicals for Anticancer Drug Development10.3389/fpls.2016.01667 ↗
10. Biological activities of curcuminoids, other biomolecules from turmeric and their derivatives—A review10.1016/j.jtcme.2016.05.005 ↗
11. Curcumin as tyrosine kinase inhibitor in cancer treatment10.1016/j.ejmech.2019.07.015 ↗
12. Potential Mechanisms of Action of Curcumin for Cancer Prevention: Focus on Cellular Signaling Pathways and miRNAs10.7150/ijbs.33710 ↗
13. Ismail, N.I., Othman, I., Abas, F., Lajis, N.H., and Naidu, R. (2019). Mechanism of Apoptosis Induced by Curcumin in Colorectal Cancer. Int. J. Mol. Sci., 20.10.3390/ijms20102454 ↗
14. Curcumin: Reclaiming the lost ground against cancer resistance
15. Nano-Based Drug Delivery System: Recent Strategies for the Treatment of Ocular Disease and Future Perspective10.2174/1872211314666191224115211 ↗
16. Progress in nanotechnology-based drug carrier in designing of curcumin nanomedicines for cancer therapy: Current state-of-the-art10.3109/1061186X.2015.1055570 ↗
17. Development of Long-Circulating Zwitterionic Cross-Linked Micelles for Active-Targeted Drug Delivery10.1021/acs.biomac.6b00168 ↗
18. Facile preparation of delivery platform of water-soluble low-molecular-weight drugs based on polyion complex vesicle (PICsome) encapsulating mesoporous silica nanoparticle10.1021/acsbiomaterials.6b00562 ↗
19. Coating and stabilization of liposomes by clathrin-inspired DNA self-assembly10.1021/acsnano.9b09453 ↗
20. Polymeric micelles: Authoritative aspects for drug delivery10.1080/1385772X.2012.688328 ↗
21. DSPE-PEG: A Distinctive Component in Drug Delivery System10.2174/1381612821666150115144003 ↗
22. Establishment and characterization of triple drug-resistant head and neck squamous cell carcinoma cell lines10.3892/mmr.2015.3768 ↗
23. Curcumin in VIP-targeted sterically stabilized phospholipid nanomicelles: A novel therapeutic approach for breast cancer and breast cancer stem cells10.1007/s13346-013-0167-6 ↗
24. Enhanced skin deposition and delivery of voriconazole using ethosomal preparations10.1080/08982104.2016.1239636 ↗
25. Factorial design based curcumin ethosomal nanocarriers for the skin cancer delivery: In vitro evaluation10.1080/08982104.2018.1556292 ↗
26. Single robust RP-HPLC analytical method for quantification of curcuminoids in commercial turmeric products, Ayurvedic medicines, and nanovesicular systems10.1080/10826076.2017.1329742 ↗
27. Effect of curcumin on growth, biofilm formation and virulence factor gene expression of Porphyromonas gingivalis10.1007/s10266-020-00514-y ↗
28. [6]-Shogaol, a dietary phenolic compound, induces oxidative stress mediated mitochondrial dependant apoptosis through activation of proapoptotic factors in Hep-2 cells10.1016/j.biopha.2016.04.044 ↗
29. Capsaicin Loaded Solid SNEDDS for Enhanced Bioavailability and Anticancer Activity: In-Vitro, In-Silico, and In-Vivo Characterization10.1016/j.xphs.2020.10.020 ↗
30. Psychiatric disorders in oral lichen planus: A preliminary case control study
31. Vulvovaginal gingival lichen planus: Report of two cases and review of literature
32. An overview of effect of lycopene and curcumin in oral leukoplakia and oral submucous fibrosis10.4103/njms.njms_324_21 ↗
33. Role of tobacco in the development of head and neck squamous cell carcinoma in an eastern Indian population
34. Head and neck cancer management and cancer stem cells implication10.1016/j.sdentj.2019.05.010 ↗
35. In Vitro and In Vivo Models for Analysis of Resistance to Anticancer Molecular Therapies10.2174/09298673113209990226 ↗
36. Gefitinib-loaded DSPE-PEG2000 nanomicelles with CD133 aptamers target lung cancer stem cells10.1186/s12957-017-1230-4 ↗
37. Camptothecin in sterically stabilized phospholipid micelles: A novel nanomedicine10.1016/j.nano.2004.11.002 ↗
38. A novel peptide nanomedicine against acute lung injury: GLP-1 in phospholipid micelles10.1007/s11095-010-0322-4 ↗
39. Curcumin-Loaded Mixed Micelles: Preparation, Characterization, and In Vitro Antitumor Activity10.1155/2018/9103120 ↗
40. Controlling the Physical Behavior and Biological Performance of Liposome Formulations Through Use of Surface Grafted Poly(ethylene Glycol)10.1023/A:1020186505848 ↗
41. Development, Optimization, and Characterization of PEGylated Nanoemulsion of Prostaglandin E1 for Long Circulation10.1208/s12249-015-0366-1 ↗
42. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation10.1016/j.biomaterials.2010.04.062 ↗
43. Curcumin-loaded nanoparticles induce apoptotic cell death through regulation of the function of MDR1 and reactive oxygen species in cisplatin-resistant CAR human oral cancer cells10.3892/ijo.2013.2050 ↗
44. Synergistic inhibitory effects of cetuximab and curcumin on human cisplatin-resistant oral cancer CAR cells through intrinsic apoptotic process
45. Novel micelle formulation of curcumin for enhancing antitumor activity and inhibiting colorectal cancer stem cells10.2147/IJN.S34702 ↗
46. The mitochondrial membrane potential (deltapsi(m)) in apoptosis: An update10.1023/A:1022945107762 ↗
47. Curcumin induces apoptosis through the mitochondria-mediated apoptotic pathway in HT-29 cells10.1631/jzus.B0820238 ↗
48. Bombesin-conjugated nanoparticles improve the cytotoxic efficacy of docetaxel against gastrin-releasing but androgen-independent prostate cancer10.2217/nnm.15.107 ↗
49. Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR10.1111/j.1745-7254.2005.00149.x ↗
50. Anti-Cancer Activity and Apoptosis Inducing Effect of Methanolic Extract of Cordia Dichotoma against Human Cancer Cell Line10.3329/bjp.v10i1.20883 ↗
51. Apoptosis: A review of programmed cell death10.1080/01926230701320337 ↗